This DiaSorin Insider Increased Their Holding In The Last Year

Insiders were net buyers of DiaSorin S.p.A.'s (BIT:DIA ) stock during the past year. That is, insiders bought more stock than they sold.

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.

View our latest analysis for DiaSorin

The Last 12 Months Of Insider Transactions At DiaSorin

The CEO, GM & Executive Director Carlo Rosa made the biggest insider purchase in the last 12 months. That single transaction was for €507k worth of shares at a price of €76.24 each. We do like to see buying, but this purchase was made at well below the current price of €103. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.

You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!

DiaSorin is not the only stock insiders are buying. So take a peek at this free list of under-the-radar companies with insider buying.

Does DiaSorin Boast High Insider Ownership?

For a common shareholder, it is worth checking how many shares are held by company insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. It's great to see that DiaSorin insiders own 4.7% of the company, worth about €258m. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

So What Do The DiaSorin Insider Transactions Indicate?

There haven't been any insider transactions in the last three months -- that doesn't mean much. But insiders have shown more of an appetite for the stock, over the last year. With high insider ownership and encouraging transactions, it seems like DiaSorin insiders think the business has merit. Therefore, you should definitely take a look at this FREE report showing analyst forecasts for DiaSorin.

Of course DiaSorin may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.